Almirall   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Barcelona Spain (1943)

Organization Overview

First Clinical Trial
2008
NCT00987246
First Marketed Drug
1963
flurandrenolide (cordran)
First NDA Approval
1963
flurandrenolide (cordran)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ALMIRALL | Almirall Hermal | Almirall Hermal GmbH | Almirall Limited | Almirall, S.A. | Almirall, SAS